Company
Thermo Fisher Scientific Inc
NYSE:TMO
Thermo Fisher Scientific Inc is engaged in serving science. The company’s Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of infection and disease.
24 stories
Prescient Therapeutics set to create scalable cell therapy platform with Thermo Fisher Scientific
The aim is to develop the next generation of OmniCAR cells that can be produced faster, more efficiently, and at a lower cost on a platform that is suitable for tech transfer to global GMP-licensed contract development and manufacturing org
Archive
Wall Street ends higher as investor confidence returns; silver futures take over as retail investor trade du jour
The Dow Jones Industrial Average added around 237 points at 30,219, while the S&P 500 gained over 57 at 3,771
Humanigen inks partnership with Thermo Fisher to speed production of coronavirus drug lenzilumab
It is making a big push with the hopes of getting Emergency Use Authorization from the US Food and Drug Administration this year
Biocept announces commercial launch of its Target Selector panel to detect lung cancer; stock jumps
Physicians and researchers can use Target Selector to detect and monitor actionable biomarkers associated with lung cancer
Valens GroWorks inks extraction agreement with Canopy Growth
The extraction specialist will process Canopy Growth’s whole flower and trim into cannabis resin
Valens Groworks to use Thermo Fisher Scientific’s instruments to study cannabis
The collaboration will showcase the level of Valens’ scientific expertise, CEO Tyler Robson says
Investments and investor services
Tecogen blazes a greener path in the energy space
The eco-friendly Texas company offers investors a compelling financial argument to go green
Thermo Fisher Scientific buys drug ingredients maker Patheon for US$7.2bn
Thermo Fisher Scientific's acquisition of Patheon represents a 35% premium to the share price at Friday's close
Affymetrix buys time on takeover controversy
Affymetrix, the takeover target which controversially spurned a higher offer for the company this week, said on Wednesday its proposed shareholder meeting to approve an offer from Thermo Fisher Scientific will proceed with a vote delayed by
Hardware & electrical equipment
Premaitha Health receives backing from US giant
Premaitha's screening technology is set to supplant the technology used in pre-natal products marketed by Brahms, a subsidiary of Thermo Fisher.